Azithromycin May Promote Cancer Relapse After Allogeneic Stem Cell Transplantation
Researchers evaluated immune and metabolic function from samples of patients in the ALLOZITHRO trial to determine how azithromycin increases relapse risk after ASCT.
Diagnosis & Disease Information
Consolidative Stem Cell Transplant May Improve Outcomes Among Patients With Peripheral T-Cell Lymphoma
Researchers sought to determine whether patients with PTCL who have a complete response after A+CHP would benefit from SCT.
Long-Term Outcomes Worse After Recovery From Severe Acute Graft-vs-Host Disease
A retrospective chart review demonstrated the long-term outcomes for patients with a history of grade 3-4 acute GVHD, compared with grade 0-1, after hematopoietic cell transplantation.
- Loading...
Loading...
Next post in Medicine
Loading... 
Loading...